Investors

Overview

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.

Shareholder Tools

Latest News
09.30.20
OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators
09.28.20
OpGen Announces Successful Completion of Study Collaboration with Karolinska Institutet on Bacterial Co-Infections in COVID-19 Pneumonia Patients and Presents Data on Unyvero HPN Panel at ECCVID 2020
09.18.20
OpGen, Inc. Announces Notice of Annual Meeting Venue Change

btn News

See All News

Upcoming Events
More events are coming soon.

btn Events

See all events